Should women with polycystic ovarian syndrome be prioritized to receive the COVID vaccine?
Wedi'i Gadw mewn:
Prif Awdur: | Duru Shah (Awdur) |
---|---|
Fformat: | Llyfr |
Cyhoeddwyd: |
Wolters Kluwer Medknow Publications,
2021-01-01T00:00:00Z.
|
Pynciau: | |
Mynediad Ar-lein: | Connect to this object online. |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
Consensus statement on the use of oral contraceptive pills in polycystic ovarian syndrome women in India
gan: Duru Shah, et al.
Cyhoeddwyd: (2018) -
Polycystic Ovary Syndrome (PCOS) transition at menopause
gan: Duru Shah, et al.
Cyhoeddwyd: (2021) -
Why should obese youth be prioritized in COVID-19 vaccination programs? A nationwide retrospective study
gan: Michelle G. Discacciati, et al.
Cyhoeddwyd: (2022) -
Should we vaccinate the better seroconverters or the most vulnerable? Game changing insights for COVID-19 vaccine prioritization policies
gan: Antoine AbdelMassih, et al.
Cyhoeddwyd: (2021) -
Urology-Related Conditions Should Not Be Overlooked in Women with Polycystic Ovary Syndrome
gan: Tariq Faisal Al-Shaiji
Cyhoeddwyd: (2021)